drugset / Trial / NCT01387308

Study in Healthy Males to Assess the Bioavailability of 4 Different Fostamatinib Tablets

NCT01387308

Phase 1 Completed 24 enrolled AstraZeneca
RandomizedCrossoverOpen-labelBasic science

Summary

Study in healthy males to assess bioavailability of 4 different fostamatinib tablets.

Timeline

Start
2011-08
Primary completion
2011-10
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Fostamatinib Small molecule 100 mg Oral
Subject Fostamatinib Small molecule 150 mg Oral

Indications

No indication recorded.